VitaLonga

Review of studies · Supplements / medicine · 17 Nov 2026

Across 16 studies and 5,679 older adults, a higher medication burden lined up with higher odds of sarcopenia

Source: BMC Geriatrics

What the research found

A systematic review and meta-analysis was published online on 17 November 2026. Sixteen observational studies included 5,679 adults aged 60 and older. The abstract does not give a sex split. Searches ran through 31 August 2026. For polypharmacy and confirmed sarcopenia, five studies gave a pooled adjusted odds ratio of 2.25 (95 percent CI 1.43 to 3.55; I-squared 31.43 percent). Eight studies gave a crude odds ratio of 2.18 (1.51 to 3.16). The count of medications, as a continuous number, did not differ (mean difference 0.01, −0.62 to 0.64). Probable or possible sarcopenia had a crude odds ratio of 1.82 (1.29 to 2.56); a Hartung-Knapp interval for that three-study result was 0.86 to 3.84 and included no difference. GRADE certainty was very low for all four outcomes. Mostly cross-sectional. Not a reason to stop a medicine on your own. DOI 10.1186/s12877-026-08689-9. Not medical advice.

Evidence level: Review of studies. This is among the stronger kinds of evidence, but one study rarely settles a question.

Read the original at BMC Geriatrics

More supplements / medicine news